Medicxi Ventures Management’s RAPT Therapeutics RAPT Stock Holding History

Medicxi Ventures Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,794,000	Closed	-$94.6M	–	5
2025 Q4	$94.6M	Hold	2,794,000	–	–	11.33%	4
2025 Q3	$72.1M	Hold	2,794,000	–	–	9.68%	4
2025 Q2	$22.4M	Hold	2,794,000	–	–	5.23%	4
2025 Q1	$27.3M	Hold	2,794,000	–	–	6.23%	4
2024 Q4	$35.3M	Buy	+2,794,000	New	+$35.5M	6.68%	4

Medicxi Ventures Management's RAPT Position: Q1 2026 in Review

Medicxi Ventures Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 2,794,000 shares — an estimated $94.6M sold.

Medicxi Ventures Management first reported a position in RAPT in Q4 2024 and held it in 5 quarters. The position peaked at $94.6M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Medicxi Ventures Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Medicxi Ventures Management sold 2,794,000 RAPT Therapeutics shares in Q1 2026, an estimated $94.6M.
Medicxi Ventures Management first reported a position in RAPT Therapeutics in Q4 2024 and held it in 5 quarters.
Medicxi Ventures Management's RAPT Therapeutics position peaked at $94.6M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Medicxi Ventures Management's 13F filing for Q1 2026, filed 21 Apr 2026.